CHIMERA BIOENGINEERING
They aspire to control the immune system. By the time a patient is sitting in front of an oncologist, cancer has evaded their immune system. Chimeric antigen receptor T-cells (CARs) are reprogrammed immune cells, hot-wired to circumvent immune-evasion. Clinical trials for CARs against liquid tumor cancers, like acute lymphoblastic leukemia and lymphoma, have shown transformative results for patients unresponsive to standard therapy. However, limited efficacy against solid tumor cancers, life... -threatening toxicities, and limited persistence are impediments to these therapies making a wider impact on cancer patients. Chimera Bioengineering solves the challenges of CARs with drug-responsive gene regulators, which allow us to re-program the "software" of the immune system. They design CAR behavior that promises to minimize toxicity, maximize efficacy and extend persistence so that CARs can lead to cures.w
CHIMERA BIOENGINEERING
Social Links:
Industry:
Bioinformatics Biotechnology Genetics Health Care
Founded:
2015-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.chimera.bio
Total Employee:
11+
Status:
Active
Contact:
(310)497-0736
Total Funding:
30.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business GoDaddy DNS Google GStatic Google Static Content
Similar Organizations
ACT Genomics
ACT Genomics is a cancer molecular information service company teamed up with experts with multiple years’ experience in oncology
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
HelixNano
Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Fabric Genomics (formerly Omicia)
Global healthcare platform for genomics-driven precision medicine. Fabric' proven AI algorithms power genomic insights.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Employees Featured
Founder
Investors List
Asian Fund For Cancer Research
Asian Fund For Cancer Research investment in Grant - Chimera Bioengineering
Sand Hill Angels
Sand Hill Angels investment in Convertible Note - Chimera Bioengineering
Life Science Angels
Life Science Angels investment in Venture Round - Chimera Bioengineering
Sand Hill Angels
Sand Hill Angels investment in Series A - Chimera Bioengineering
Sand Hill Angels
Sand Hill Angels investment in Seed Round - Chimera Bioengineering
Kairos Ventures
Kairos Ventures investment in Seed Round - Chimera Bioengineering
Sand Hill Angels
Sand Hill Angels investment in Convertible Note - Chimera Bioengineering
The Angels' Forum
The Angels' Forum investment in Convertible Note - Chimera Bioengineering
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-28 | Chimera Appoints New CEO, Wins AFCR BRACE Award, and Accelerates towards the Clinic with TME-Modifying CAR-T Therapies for Solid Tumors |
Official Site Inspections
http://www.chimera.bio
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
